Most people with substance use concerns who had used psychedelics in the past year thought that psychosocial support after their experiences would be useful. Of 108 participants, 94 (87.0%) considered integration support helpful. Among those interested, most preferred individual support led by a psychologist (67.0%) or a peer worker with lived experience of psychedelic use (58.5%), focusing on applying insights from the psychedelic experience to daily life (63.0%). The findings suggest potential benefits for offering such support and could be explored further with qualitative research.
People with methamphetamine use disorder who underwent ketamine-assisted psychotherapy described the treatment as a multi-stage process rather than a simple drug effect. Participants reported that ketamine created a temporary state of reduced emotional and cognitive reactivity, which they called 'psychological space,' making them more receptive to psychotherapy. However, behavioral changes—including reduced methamphetamine use—were variable and depended on ongoing therapeutic engagement, personal motivation, and life context. Participants were uncertain whether improvements came from the ketamine, the therapy, or the supportive environment. Acceptability was generally high when treatment occurred in a structured clinical setting.